Mounjaro Injection Results: What to Expect (October 2026)

01 · The core answer

What Mounjaro injection results look like in practice

Mounjaro results are gradual by design, and the honest answer to "how quickly will I lose weight" is: slowly at first, then steadily. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month.¹

The best-known numbers come from SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

That trial lasted 72 weeks, not a few weeks. Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.¹

02 · Your next decision

Is this relevant to you, and what should you do next?

If you are already on Mounjaro, the useful question is whether your trend is moving the right way over weeks, not whether this week's scale reading looks good. If you are still deciding, the useful question is whether you would be comfortable with a slow, steady process and regular prescriber reviews.

Your prescriber reviews treatment response. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. Our free consultation has no charge and no obligation. If you are ready to look at the starting pen, the Mounjaro pen costs £169.99 at 2.5mg, and your first 2.5mg pen is £129.99 with code FIRST40. For the wider picture on support and treatment options, see our weight loss clinic.

For a longer look at what people can expect across the whole journey, our guide to Mounjaro weight loss results goes further, and real results in the UK covers how outcomes differ from person to person.

03 · Trial results

What the SURMOUNT-1 trial measured

The headline evidence for tirzepatide in weight management is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

The result is reported by dose, not as one number for everyone. It is an average, so some participants lost more and some less. And it was compared with a lifestyle-only group, which also lost weight but far less. The comparison group matters because it shows what diet and activity alone achieved in the same setting.

The trial also reported how many people reached particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² These threshold figures help show the spread of outcomes, not only the middle.

What the trial does not tell you is how you personally will respond. A trial average is not a forecast for one person, and a smaller loss than the headline figure does not mean treatment has failed. Participants differ in starting weight, diet, activity, sleep, other medicines and how well they tolerate each dose step. The sensible use of these figures is to understand the range of what is possible with consistent weekly treatment, a reduced-calorie diet and more physical activity.

It is also worth being clear about what the trial duration implies. Results were measured at 72 weeks, which is well over a year of treatment. Anyone expecting the full headline averages in a few weeks is reading the evidence wrongly. The sensible framing is that the trial describes a long process with the dose rising over time.

If you want to compare with other numbers you see online, check three things: which trial it came from, which dose it applies to, and how long people were treated. Figures that do not state all three are not much use for planning. Our page on getting the best results on Mounjaro covers the habits that sit alongside the medicine.

04 · Early weeks

The early weeks on 2.5mg: what is normal

The early weeks on 2.5mg are about adjustment, and experiences differ widely. Everyone starts Mounjaro on 2.5mg weekly. This starting dose is about letting your body adjust, not about weight loss itself.¹ That framing explains why some people see little change on the scales at the start.

Some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

A useful way to think about this stage is that you are building a routine. Pick a day and time you will remember and keep to it. There is no "best" time of day: Mounjaro works the same morning or evening, with or without food. What matters is the same day each week. Many people choose a weekend morning so early side effects fall on days off.

Technique also matters in the early weeks. The pen is injected under the skin, and the licensed sites are the stomach area, the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Our guides to injection technique and injection locations walk through this step by step, and preparing for your first dose covers what to have ready.

If early results feel underwhelming, resist the urge to read too much into them. A lack of dramatic change at the lowest dose is expected by design. The starting dose exists for tolerability, and the dose you respond to may still be ahead of you. If side effects are troublesome, tell your prescriber.

Equally, a strong early response is not a reason to skip steps or move faster than the licence allows. Dose increases follow a minimum interval, and your prescriber guides the pace based on how you respond and tolerate treatment.

If anything about the early weeks worries you, the answer is to speak with your prescriber, not to adjust the dose yourself.

05 · Dose and results

How your dose shapes your results

Dose matters for results, but higher is not automatically better. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹ Many people settle at a maintenance dose of 5mg, 10mg or 15mg, and your prescriber will guide the right pace.

The trial figures follow the same pattern. Average losses at 72 weeks were larger on higher doses, but they were also substantial on 5mg. That is why a person who does well and tolerates 5mg may reasonably stay there, while another person moves higher because their response has levelled off and they tolerate the next step.

Each KwikPen contains four weekly doses, and the dose can step up after at least 4 weeks on each dose, depending on how you respond and tolerate it. Not everyone steps up at the first opportunity. Some stay longer at a dose because of side effects or because they are already responding well.

A few practical points affect how consistently you receive each dose. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.¹ You can change your weekly injection day if needed, as long as there are at least 3 days between two doses.

The dial on the pen is set by turning the dose knob until the dose indicator shows the correct dose in the window.

Finally, results are not improved by altering the schedule. Altering doses outside the licence means unknown dosing accuracy and no safety data.

06 · Three-month view

What to expect by around three months

At around the three-month point, most people are still on the lower rungs of the dose ladder, so losses are modest compared with the headline trial figures. In SURMOUNT-1, average weight loss built month by month, which is why the 72-week figures are not a guide to a short-term check.²

A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.¹ Slower early progress does not predict failure, because the dose you respond to may still be ahead of you. We would rather you plan around that realistic picture than around a fast-loss story that sets you up for disappointment.

It helps to understand why the middle months matter. By then, you will have had time to settle into the weekly routine, learn how your appetite changes after each injection, and notice which foods sit well. Those habits are as important as the medicine, because the medicine works alongside a reduced-calorie diet and increased physical activity.

This stage is also when the formal review point comes into view. Your prescriber reviews response over time. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Note the wording: the highest tolerated dose. A review at the early dose is not the same as a review at your top tolerated dose.

What should you track in the meantime? Weekly weight at the same time of day on the same scale is useful, but the trend matters more than any one reading. Add measurements such as waist or how clothes fit, and make notes on appetite, energy and side effects. Our free companion app, GLPTrackr, is built for tracking a GLP-1 journey on iOS and Android.

Do not compare your week-by-week numbers with people online. They differ in starting point, dose timing, tolerance and lifestyle, and the figures they quote rarely state a trial, a dose or a duration. If your pace feels slow, talk it through at your monthly review rather than changing anything on your own.

Remember also that a medicine only helps if you keep taking it as directed. Consistent weekly dosing and good routines are the main things in your control through these months.

07 · Plateaus

Plateaus and slow progress

Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ A flat fortnight in the middle of a good run is not evidence that the medicine has stopped working.

Within the licence, the responses are practical. Start by reviewing food intake honestly, because portions drift back up without anyone noticing. Protect protein and activity, as both support a reduced-calorie diet and keep you moving. Check the basics too, such as sleep and alcohol. Finally, discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.

A plateau is not a reason to double doses or add unlicensed products. That deserves emphasis, because plateaus are when people go looking for shortcuts. Dose stretching, extra injections and products sold with dramatic weight-loss claims have no place in a safe plan. Doubling a dose means unknown effects and no safety data behind it.

It also helps to distinguish between a plateau and a genuine lack of response. A plateau is a pause in a longer downward trend. A lack of response shows across many weeks at the highest tolerated dose, and your prescriber has a formal review for that situation. If you are somewhere between the two, a monthly review is the right place to talk it through.

Other factors can influence the scale in the short term. Early loss includes water weight, so changes in fluid can mask fat loss in either direction. That is why trends over weeks beat single weigh-ins.

Sometimes the plateau is partly about expectations. If you started quickly and then slowed, the early part may have included water, while the slower later pace is the steadier pattern. If your appetite feels less controlled than before, say so. It may be a sign to talk about whether your dose is right.

If you are unsure what to adjust, our guide on how to use the injection and maximise results covers the daily habits that tend to matter, and you can always contact our support team on weekdays for questions about your treatment.

08 · Beyond the scales

Results beyond the scales

Weight is only one measure of how treatment is going. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, and individual results vary.

That wider picture is why prescribers talk about weight management as health management rather than appearance. If you only watch the scale, you may miss progress that shows up in other ways: a looser waistband, easier movement, better readings at a routine check, or a change in how you feel about food.

Where fat comes off first varies between people, and nobody can choose it.

Mounjaro itself acts on gut-hormone receptors. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

This also helps explain the "signs" people look for. The first signs of progress are often practical rather than numerical: smaller portions feel satisfying, you think about food less between meals, and clothes fit differently. These are everyday observations, not clinical measures, so treat them as encouragement and let your prescriber's review and your tracked trend be the real guide.

If you have other conditions, such as raised blood pressure or type 2 diabetes, talk to your prescriber about how treatment changes might affect them. Insulin and sulfonylureas in particular may need dose adjustment because of the risk of low blood sugar, which is a conversation for your prescriber, not a reason to change anything yourself.

Keep a record of other markers where you can, such as readings from routine checks, and share them at reviews. A fuller picture helps your prescriber judge whether treatment is doing its job.

09 · Signs of progress

Signs of progress, stones and how noticeable change is

People often ask how to tell fat is leaving the body, what the first signs of losing weight are, and how much loss is noticeable.

Start with how to judge progress. Because early loss includes water weight, a drop in the first days is not a clean measure of fat. The trend over weeks matters more than any single weigh-in. Useful, low-stress indicators include your weekly average weight, how clothes fit, waist measurement taken the same way each time, and changes in appetite and energy.

As for how noticeable a given loss is, that depends on your height, build and starting point, so there is no universal answer. A stone may be very visible to one person and barely visible to another.

Many things influence weight, including sleep, activity, other medicines and health conditions, and your prescriber is the right person to discuss your own circumstances.

A few signs deserve a conversation with your prescriber rather than celebration or worry. If you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away. If you feel unwell or notice any symptom that concerns you, tell your prescriber. Report suspected side effects through the Yellow Card scheme as well.¹⁹ Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.

Finally, think about how you define a good result. For some people it is a number on the scale. For others it is easier movement, better health markers or reduced hunger. Agree a realistic goal with your prescriber, and review it as you move through the dose ladder. Our overview of weight loss injection results compares what different people tend to look for.

Keep in mind that Mounjaro is used alongside a reduced-calorie diet and increased physical activity. The medicine supports your efforts and does not replace them.

10 · Stopping and staying on track

Staying on track: storage, supply and stopping

Results depend on taking each dose properly, so a few practical points about storage and supply matter. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use — useful for short trips — and must then be thrown away. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

Travelling is manageable. You can fly with Mounjaro. Carry pens in hand luggage, because hold luggage can fall below freezing, ideally in a cool bag with the prescription label or a copy of your prescription. Unopened pens should be kept in the fridge and keep until the expiry date printed on the box. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit.

Supply matters for consistency, and for safety. Counterfeit weight-loss injections are a real risk, and the MHRA publishes alerts about them.⁷ Be wary of anyone offering to supply without a consultation or prescription. We supply genuine KwikPens through official LillyDirect supply, direct from Eli Lilly's UK distribution, and we are a GPhC-registered pharmacy, number 9012878. You can check our registration on the GPhC register.¹²

If you stop treatment, the medicine takes time to leave your body. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ If you are thinking about stopping, speak to your prescriber first so you can plan sensibly.

Ongoing support is part of getting results. Our prescribing team provides monthly reviews, dose-titration and follow-up assessments, and side-effect support. Repeat orders re-check suitability, and there is no auto-shipping. Dispatch is the same day when ordered by 3pm, and delivery is free next-day tracked in temperature-controlled packaging.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS and private

Getting treatment: NHS and private routes

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

If you go private, the process is straightforward. First, complete a free online consultation: a short health questionnaire with no charge and no obligation. Second, a GPhC-registered prescriber reviews it, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses and dispatches, with free next-day tracked delivery.

On cost, the standard price of the starting pen is £169.99. A new customer's first 2.5mg pen is £129.99 with code FIRST40, and every later order is £25 off the standard price (code DOSE25). If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. Prices were checked 11 October 2026, and all six doses are in stock.

Compare that with your own goals. A slower, steady result suits some people who can plan for the long term, and the dose ladder is built that way. Because results build over many months, cost planning over a longer period is more realistic than judging by one pen. At standard prices, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg; a new customer's first order is £40 less and every later order £25 less.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

For personal advice about whether treatment suits you, complete the consultation or speak with your own GP. We offer payment by Visa, Mastercard or Klarna, with pay-monthly options and no subscription lock-in.